

Riconpharma India Profile
Key Indicators
- Authorised Capital ₹ 6.50 Cr
- Paid Up Capital ₹ 4.83 Cr
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -19.80%
- Profit Growth -9.71%
- Ebitda -3.85%
- Net Worth 7.49%
- Total Assets 9.21%
About Riconpharma India
Riconpharma India Private Limited (RIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 March 2009 and has a history of 16 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.50 Cr and a paid-up capital of Rs 4.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Valiveti Brahmaji, Mukteeshwar Gande, and Nageswara Venkata serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TG2009PTC062946
- Company No.
062946
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Riconpharma India Private Limited offer?
Riconpharma India Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Cardiac Drugs, Common Disease Medicines, Pharmaceutical Tablets, Anaemia Medicine, TB, Tumor & Cancer Drugs, Anti Cancer Injection, Skin Ointment.
Who are the key members and board of directors at Riconpharma India?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Valiveti Brahmaji ![]() | Director | 01-Oct-2014 | Current |
Mukteeshwar Gande ![]() | Director | 12-Feb-2015 | Current |
Nageswara Venkata ![]() | Director | 23-Jan-2018 | Current |
Financial Performance of Riconpharma India.
Riconpharma India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.8% decrease. The company also saw a slight decrease in profitability, with a 9.71% decrease in profit. The company's net worth moved up by a moderate rise of 7.49%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Riconpharma India?
In 2023, Riconpharma India had a promoter holding of 99.71% and a public holding of 0.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Indian Institute Of Cancer And Research Private Limited
Valiveti Brahmaji is a mutual person
- Difgen Pharmaceuticals Private Limited
Valiveti Brahmaji is a mutual person
- Fermac Bio Private Limited
Valiveti Brahmaji is a mutual person
Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Riconpharma India?
Riconpharma India has a workforce of 87 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Riconpharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riconpharma India's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Riconpharma India
Recent activity within the organization
- Annual General Meeting
Riconpharma India Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Riconpharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Director Appointment
Nageswara Rao Muntha Venkata was appointed as a Director was appointed as a Director on 23 Jan 2018 & has been associated with this company since 7 years 3 months .
- Director Appointment
Mukteeshwar Gande was appointed as a Director was appointed as a Director on 12 Feb 2015 & has been associated with this company since 10 years 3 months .
- Director Appointment
Valiveti Brahmaji was appointed as a Director was appointed as a Director on 01 Oct 2014 & has been associated with this company since 10 years 7 months .
- Company Incorporation
Riconpharma India Private Limited was registered on 03 Mar 2009 with Roc Hyderabad & aged 16 years 2 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Riconpharma India Private Limited?
Riconpharma India Private Limited was incorporated on 03 Mar 2009.
What is authorized share capital and paid-up capital of Riconpharma India Private Limited?
The authorized share capital of Riconpharma India Private Limited is ₹ 6.50 Cr and paid-up capital is ₹ 4.83 Cr.
Who are the current board members & directors of Riconpharma India Private Limited?
Currently 3 directors are associated with Riconpharma India Private Limited.
- Valiveti Brahmaji
- Mukteeshwar Gande
- Nageswara Rao Muntha Venkata
What is the registered address of Riconpharma India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Riconpharma India Private Limited is Ground 1St 2Nd Floors At Plot No-5C, Ida Uppal India, Hyderabad, Telangana, 500039.
What is the corporate identification number (CIN) and company number of Riconpharma India Private Limited?
The corporate identification number (CIN) of Riconpharma India Private Limited is U24232TG2009PTC062946 and the company number is 062946 as per Ministry of Corporate Affairs (MCA).
What is the official website of Riconpharma India Private Limited?
The Official website of Riconpharma India Private Limited is https://www.riconpharma.com
What has been the recent revenue trend for Riconpharma India Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Riconpharma India Private Limited has fallen by -19.80%.
How many employees does Riconpharma India Private Limited currently have?
As Per 2023 financial reports, 87 employees are currently employed by Riconpharma India Private Limited.
What change has been observed in the net worth of Riconpharma India Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Riconpharma India Private Limited has experienced an upsurge of 7.49%.
When was the last Balance Sheet of Riconpharma India Private Limited filed with the ROC?
The most recent Balance Sheet for Riconpharma India Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Srilatha BillaDirector
PB
Praveen BillaDirectorDK
Develpalli KumarDirectorSV
Satyanaryana ValivetiDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India